ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >Sitagliptin N-Phoshate IMpurity
Sitagliptin N-Phoshate IMpurity
- CAS No.
- 1351498-25-3
- Chemical Name:
- Sitagliptin N-Phoshate IMpurity
- Synonyms
- Sitagliptin Impurity 33;Sitagliptin N-Phoshate IMpurity;(R)-(4-oxo-4-(3-(trifluoromethyl);Phosphoramidic acid, N-[3-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-oxo-1-[(2,4,5-trifluorophenyl)methyl]propyl]-;(R)-(4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)phosphoramidic acid? (Sitagliptin Impurity)
- CBNumber:
- CB72675706
- Molecular Formula:
- C16H16F6N5O4P
- Molecular Weight:
- 487.29
- MOL File:
- 1351498-25-3.mol
Sitagliptin N-Phoshate IMpurity Preparation Products And Raw materials
Raw materials
Preparation Products
Sitagliptin N-Phoshate IMpurity Suppliers
Global( 20)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
SynZeal Research Pvt Ltd | +1 226-802-2078 | Gujarat, India | 6522 | 58 | Inquiry |
China National Standard Pharmaceutical Corporation Limited | +8615391658522 | China | 11927 | 58 | Inquiry |
Shanghai Zerui Biotechnology Co., Ltd. | 021-54580889 18321124657 | China | 10614 | 58 | Inquiry |
Hubei Ruinuo Pharmaceutical Technology Co., Ltd | 13165688766 | China | 5000 | 58 | Inquiry |
QUALITY CONTROL SOLUTIONS LTD. | 13670046396 | China | 18865 | 58 | Inquiry |
Hubei De'ao Chemical Research Pharmaceutical Technology Co., Ltd | 18502726233; 18502726233 | China | 9486 | 58 | Inquiry |
BOC Sciences | 1-631-485-4226; 16314854226 | United States | 14059 | 65 | Inquiry |
Shanghai Haohong Scientific Co., Ltd. | 400-400-8210725 | China | 40041 | 58 | Inquiry |
Nantong Hanfang Biotechnology Co. , Ltd. | 18616537568 | China | 30968 | 58 | Inquiry |
Nanjing XiZe Biotechnology CO., Ltd. | 025-58362220 15250997978 | China | 7775 | 55 | Inquiry |
1351498-25-3(Sitagliptin N-Phoshate IMpurity)Related Search:
Duloxetine N-DesMethyl Metabolite
N'-[(2Z)-Piperazin-2-ylidene]trifluoroacetohydrazide
Sitagliptin impurity H HCl
(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione
Methyl 3-Oxo-4-(2,4,5-trifluorophenyl)butanoate
Sitagliptin Impurity 26
Benzenebutanoicacid,b-aMino-2,4,5-trifluoro-,Methylester,(bR)-
Sitagliptin Impurity 14
Sitagliptin Impurity 34
Sitagliptin Impurity 31
4-[3-(Methylamino)-1-(2-thienyl)propyl]-
Sitagliptin phosphate
3-THIOPHENEPROPANAMINE, N,N-DIMETHYL-GAMMA-(1-NAPHTHALENYLOXY)-, ETHANEDIOATE(1:1)
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one
Sitagliptin Defuoro IMpurity 3
chevron_left
1of4
chevron_right
Sitagliptin N-Phoshate IMpurity
Sitagliptin Impurity 33
(R)-(4-oxo-4-(3-(trifluoromethyl)
Phosphoramidic acid, N-[3-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-oxo-1-[(2,4,5-trifluorophenyl)methyl]propyl]-
(R)-(4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)phosphoramidic acid? (Sitagliptin Impurity)
1351498-25-3
C16H16F6N5O4P